Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Mingze Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China. Hauptthemen laut MEDLINE: Nanoparticles, N-Acetylneuraminic Acid, Lung Neoplasms, Hydroxyquinolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Epigenetic homeostasis is integral to the development of malignant tumors. Combining epigenetic drugs with chemotherapy is a promising strategy to overcome the challenges in treating lung metastasis from melanoma. In this study, we constructed sialic acid-modified ibrutinib-phospholipid complex nanoparticles (SA-IBR-NPs) to actively target and deliver the drug to lung metastasis sites through the mononuclear phagocytic system (MPS) pathway. A highly soluble 5-Carboxy-8-hydroxyquinoline-arginine salt (IOX1-Arg) was also developed to inhibit tumor cells' intrinsic immune escape mechanisms. The combined administration of IOX1-Arg and SA-IBR-NPs significantly reduced the migration and invasion abilities of B16F10 cells and inhibited lung metastasis. The number of tumor nodules in experimental groups (including single-agent treatment groups, non-SA-modified nanoparticle groups, and non-IOX1-Arg combined groups) was 3.67-28.00 times higher than that of the IOX1-Arg + SA-IBR-NPs. The malignant index of tumor metastasis in single therapy or plain nanoparticle groups was 5.38-1062.29 times higher than that of the IOX1-Arg + SA-IBR-NP treatments, as well. This combination therapy also increased the levels of cytotoxic T cells. The antitumor immune response was effectively restructured by blocking the intrinsic escape mechanism of tumor cells and simultaneously inhibiting the immunosuppressive factors in the microenvironment. This strategy presents a novel approach to enhancing targeted therapy for metastatic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.
ORCID-Profile: Yanzhi Song, Yihui Deng
Zitieren
APA
Li, M., Ge, R., Zhu, H., Sun, Y., Li, Y., Liu, X., Song, Y., & Deng, Y. (2026). Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01117
Vancouver
Li M, Ge R, Zhu H, Sun Y, Li Y, Liu X, et al. Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01117
BibTeX
@article{Li2026,
author = {Li, Mingze and Ge, Ruirui and Zhu, Haidi and Sun, Yuejia and Li, Yantong and Liu, Xinrong and Song, Yanzhi and Deng, Yihui},
title = {Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01117}
}
EUVIMED